News

Artificial intelligence startups captured the majority of global venture capital funding in the first quarter of 2025.
Examining the transfer data presented last week's Central Board meeting, what it might mean and what it could lead to in the ...
Kochhar & Co acted as legal counsel to Tonbo Imaging India Limited in raising ₹175 crore in a Series D pre-IPO funding round ...
ShotSpotter’s parent company is among eight firms that submitted proposals for contracts to provide “gun violence detection ...
"It was an open canvas that allowed us to be creative with the design and flow of our entire wedding day," the bride says of ...
Weems’ company is working to sell the city Dragonfly, a system developed by ... Another applicant, Tampa-based Blue Hammer Technology, has an artificial intelligence platform that’s used ...
A Concise Chinese-English Dictionary for Lovers”, her novel published in 2007, follows a Chinese woman studying in London.
Find people pictures quickly, weed out duff group shots and cull video with artificial intelligence in Excire's latest ...
Dragonfly has an ongoing phase 1/2 clinical trial of DF6002 for patients with advanced solid tumours, which began in July 2020 after the FDA granted clearance to begin clinical trials in May.
Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cancer and ...